Indian Pharma Co. Can't Revive Claim Over Xifaxan Royalties

Indian Pharma Co. Can’t Revive Claim Over Xifaxan Royalties

Source Node: 2601836
By Caroline Simson (April 21, 2023, 10:17 PM EDT) — An English judge on Friday refused to order an arbitrator to reconsider his award siding with a New Jersey specialty pharmaceutical company in a licensing dispute involving a diarrhea drug, ruling that the parties had had a clear opportunity to address all the issues….

Time Stamp:

More from Law 360